Above and beyond RF
Experience a modern device that delivers complete and consistent depth of coverage, without using RF energy only to ablate endometrial tissue.
Plasma dynamically targets least ablated tissue
The right dose of power for each patient
Best-in-class clinical results
Every patient will receive a 120 second treatment cycle, however the amount of energy delivered during the 120 seconds will vary from patient to patient depending on uterine cavity size and thickness of the endometrium. Each ablation starts with a maximum of 40W of power and declines over the course of the ablation as the impedance within the cavity increases.
Minerva ES does not rely solely on direct tissue contact to achieve optimal ablation. Three simultaneous and complementary methods of tissue ablation are being employed by Minerva, providing a truly global ablation.
Minerva ES is the only ablation system that modulates the power level over the course of the ablation cycle. The controller adjusts power in real time by assessing the changes in the state of the uterine cavity during the ablation process, with measurements being taken and adjustments made 50 times per second. During the ablation process, the area of unablated tissue decreases, and power starts dropping accordingly, with plasma being redirected. Thus focusing ONLY on the least ablated endometrium for a uniform surface area coverage and depth of ablation.
Plasma is another term for ionized gas, in this case argon. The argon gas inside the membrane is ionized by the RF energy delivered to the handpiece from the Minerva Controller.
The cervix should be dilated. An 8mm Hegar dilator is included in the device packaging. The dilator has graduated length markings to ensure accurate measurement of the cervix.
Do not turn off the Controller. Most error codes may be resolved via troubleshooting or replacing the device. Then the Controller will proceed through the safety checks and resume and ablate for the remaining treatment time. In rare instances, a hard fault may be encountered that would require cycling off power to the Controller. Consult the Operator’s Manual or call Minerva for more information.
A maximum of 2 times. If more inflations are needed, reassess to make sure the device is properly positioned in the uterine cavity and rule out uterine perforation.
In a controlled clinical study conducted for a FDA approval, Minerva ES achieves an Amenorrhea rate of 72%, or 7 out of 10 women.
Minerva has a low hysterectomy rate, with only 1 out of every 100 patients requiring hysterectomy at 3 years, compared to 6 out of every 100 patients for the closest competitor.
According to the FDA, hysteroscopy is optional when performing endometrial ablation.
The argon cartridge will last for approximately 7 treatments. A CO2 cartridge will last for approximately 25 treatments.
No. According to the product labeling, the use of Minerva ES, and all other second-generation endometrial ablation technologies, is contraindicated in a patient with any anatomic condition that could lead to weakening of the myometrium. Please consult instructions for use for complete indications, contraindications, warnings and precautions.
The Minerva treatment should not be performed concomitantly with the placement of the Essure device. The safety and effectiveness of the Minerva treatment has not been evaluated in patients with the Essure device.